Barclays Adjusts Estimates on Calumet Specialty Products (CLMT); Acquisition Increases Size and Footprint, But Creates Financing Need
Tweet Send to a Friend
Barclays maintains an 'Equalweight' on Calumet Specialty Products Partners (NASDAQ: CLMT) price target of $22.00.
Barclays analyst says, "Pending refinery ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Barclays analyst says, "Pending refinery ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
